Physician profile
Carol Hoffman
NPI 1487760153
$727.61
in general payments reported to CMS, 2019-2025
11 companies · $370 in 2025
The $370 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.00 · 2020: $36.33 · 2021: $14.73 · 2022: $242 · 2023: $14.90 · 2024: $34.92 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $187.17 | 2024-2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Glaukos Corporation | $127.63 | 2022 | |
| Sun Pharmaceutical Industries INC. | $122.07 | 2019-2025 | Cequa |
| Alcon Vision LLC | $96.30 | 2025 | Clareon Panoptix Pro, Eysuvis, Clareon |
| Bausch & Lomb Americas INC. | $48.18 | 2024-2025 | Miebo, Xiidra |
| Sight Sciences, INC. | $36.98 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $36.33 | 2020 | |
| Biotissue Holdings INC. | $21.85 | 2022 | |
| Abbvie INC. | $20.14 | 2025 | |
| Dompe US, INC. | $18.50 | 2025 | Oxervate |
| Eyevance Pharmaceuticals LLC | $12.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.